• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Graf Acquisition Corp. IV

    2/11/22 4:10:39 PM ET
    $GFOR
    Blank Checks
    Finance
    Get the next $GFOR alert in real time by email
    SC 13G 1 tm226139d1_sc13g.htm SC 13G

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    (Amendment No. )*
    Under the Securities Exchange Act of 1934

     

    Graf Acquisition Corp. IV
    (Name of Issuer)

     

    Common Stock, par value $0.0001 per share
    (Titles of Class of Securities)

     

    384272100
    (CUSIP Number)

     

    December 31, 2021
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨ Rule 13d-1(b)
       
    ¨ Rule 13d-1(c)
       
    x Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out of a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. 384272100 Schedule 13G  

     

    1  

    NAME OF REPORTING PERSON

     

    Graf Acquisition Partners IV LLC

    2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ¨ (b) ¨

    3   SEC USE ONLY
    4  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH:
      5  

    SOLE VOTING POWER

     

    4,210,375 (1)(2)

      6  

    SHARED VOTING POWER

     

    - 0 -

      7  

    SOLE DISPOSITIVE POWER

     

    4,210,375 (1)(2)

      8  

    SHARED DISPOSITIVE POWER

     

    - 0 -

    9  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    4,210,375 (1)(2)

    10  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    19.6% (3)

    12  

    TYPE OF REPORTING PERSON

     

    OO

     

     

    (1)The securities are held directly by Graf Acquisition Partners IV LLC (the “Sponsor”). James A. Graf is the managing member of the Sponsor and has sole voting and investment discretion with respect to the securities held by the Sponsor.

    (2)Excludes 4,721,533 shares of common stock issuable upon the exercise of 4,721,533 private placement warrants of the Issuer. Each warrant is exercisable to purchase one share of common stock at $11.50 per share, subject to adjustment, becomes exercisable beginning 30 days after the completion of the Issuer’s initial business combination and expires five years after the completion of the Issuer’s initial business combination or earlier upon redemption or liquidation, each as is described under the heading “Description of Securities—Warrants” in the Issuer’s registration statement on Form S-1 (File No. 333-253411).

    (3)Based on 21,451,875 shares of common stock outstanding as of December 31, 2021.

     

    2

     

     

    CUSIP No. 384272100 Schedule 13G  

     

    1  

    NAME OF REPORTING PERSON

     

    James A. Graf

    2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ¨ (b) ¨

    3   SEC USE ONLY
    4  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH:
      5  

    SOLE VOTING POWER

     

    4,210,375 (1)(2)

      6  

    SHARED VOTING POWER

     

    - 0 -

      7  

    SOLE DISPOSITIVE POWER

     

    4,210,375 (1)(2)

      8  

    SHARED DISPOSITIVE POWER

     

    - 0 -

    9  

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    4,210,375 (1)(2)

    10  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    19.6% (3)

    12  

    TYPE OF REPORTING PERSON

     

    IN

     

     

    (1)The securities are held directly by Sponsor. James A. Graf is the managing member of the Sponsor and has sole voting and investment discretion with respect to the securities held by the Sponsor.

    (2)Excludes 4,721,533 shares of common stock issuable upon the exercise of 4,721,533 private placement warrants of the Issuer. Each warrant is exercisable to purchase one share of common stock at $11.50 per share, subject to adjustment, becomes exercisable beginning 30 days after the completion of the Issuer’s initial business combination and expires five years after the completion of the Issuer’s initial business combination or earlier upon redemption or liquidation, each as is described under the heading “Description of Securities—Warrants” in the Issuer’s registration statement on Form S-1 (File No. 333-253411).

    (3)Based on 21,452,875 shares of common stock outstanding as of December 31, 2021.

     

    3

     

     

     

    Item 1(a). Name of Issuer:

     

    Graf Acquisition Corp. IV

     

    Item 1(b). Address of Issuer’s Principal Executive Offices:

     

    1790 Hughes Landing Blvd., Suite 400

    The Woodlands, Texas 77380

     

    Item 2(a). Name of Person Filing:

     

    This statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):

     

    1.            Graf Acquisition Partners IV LLC

    2.            James A. Graf

     

    Item 2(b). Address of Principal Business Office or, if none, Residence:

     

    The principal business address of each of the Reporting Persons is as follows:

     

    1790 Hughes Landing Blvd., Suite 400

    The Woodlands, Texas 77380

     

    Item 2(c). Citizenship:

     

    See response to Item 4 on the cover page.

     

    Item 2(d). Titles of Classes of Securities:

     

    Common Stock, par value $0.0001 per share.

     

    Item 2(e). CUSIP Number:

     

    384272100

     

    Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a(n):

     

    (a) ¨ Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78o).
         
    (b) ¨ Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).
         
    (c) ¨ Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).
         
    (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
         
    (e) ¨ Investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
         
    (f) ¨ Employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
         
    (g) ¨ Parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
         
    (h) ¨ Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
         
    (i) ¨ Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
         
    (j) ¨ Non-U.S. institution, in accordance with § 240.13d-1(b)(1)(ii)(J).
         
    (k) ¨ Group in accordance with §240.13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with §240. 13d-1(b)(1)(ii)(J), please specify the type of institution: ______________.

     

    4

     

     

    Item 4. Ownership

     

    (a)Amount beneficially owned:

     

    See response to Item 9 on the cover page.

     

    (b)Percent of class:

     

    See response to Item 11 on the cover page.

     

    (c)Number of shares as to which such person has:

     

    (i)Sole power to vote or to direct the vote:

     

    See response to Item 5 on the cover page.

     

    (ii)Shared power to vote or to direct the vote:

     

    See response to Item 6 on the cover page.

     

    (iii)Sole power to dispose or to direct the disposition of:

     

    See response to Item 7 on the cover page.

     

    (iv)Shared power to dispose or to direct the disposition of:

     

    See response to Item 8 on the cover page.

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Not Applicable.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    Not Applicable.

     

    Item 8. Identification and Classification of Members of the Group.

     

    Not Applicable.

     

    Item 9. Notice of Dissolution of Group.

     

    Not Applicable.

     

    Item 10. Certification.

     

    Not Applicable.

     

    5

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 11, 2022

     

    Graf Acquisition Partners IV LLC  
       
    By: /s/ James A. Graf  
    Name: James A. Graf  
    Title: Manager  
         
    James A. Graf  
         
    By: /s/ James A. Graf  
    Name: James A. Graf  

     

    6

     

     

    Exhibit Index

     

    Exhibit 
    No.
      Description
    Exhibit 1   Joint Filing Agreement, dated as of February 11, 2022, by and among Graf Acquisition Partners IV LLC and James A. Graf.

     

    7

     

     

    Get the next $GFOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GFOR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GFOR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Song Paul Y. bought $500 worth of shares (151 units at $3.30), increasing direct ownership by 0.09% to 171,121 units (SEC Form 4)

    4 - NKGen Biotech, Inc. (0001845459) (Issuer)

    12/7/23 5:23:12 PM ET
    $GFOR
    Blank Checks
    Finance

    Song Paul Y. bought $850 worth of shares (268 units at $3.17), increasing direct ownership by 0.16% to 170,969 units (SEC Form 4)

    4 - NKGen Biotech, Inc. (0001845459) (Issuer)

    12/5/23 3:51:22 PM ET
    $GFOR
    Blank Checks
    Finance

    Graf James A bought $2,172 worth of shares (670 units at $3.24), increasing direct ownership by 2,913% to 693 units (SEC Form 4)

    4 - NKGen Biotech, Inc. (0001845459) (Issuer)

    12/5/23 3:50:10 PM ET
    $GFOR
    Blank Checks
    Finance

    $GFOR
    SEC Filings

    View All

    Graf Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - NKGen Biotech, Inc. (0001845459) (Filer)

    2/12/24 9:25:50 AM ET
    $GFOR
    Blank Checks
    Finance

    Graf Acquisition Corp. IV filed SEC Form 8-K: Leadership Update

    8-K - NKGen Biotech, Inc. (0001845459) (Filer)

    2/8/24 5:07:33 PM ET
    $GFOR
    Blank Checks
    Finance

    Graf Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - NKGen Biotech, Inc. (0001845459) (Filer)

    1/22/24 6:12:43 AM ET
    $GFOR
    Blank Checks
    Finance

    $GFOR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 25, 2023

    THE WOODLANDS, Texas, Sept. 22, 2023 /PRNewswire/ -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR.U, GFOR WS))) (the "Company" or "Graf"), announced today that on September 20, 2023, it adjourned, without conducting any business, the special meeting of its stockholders to be held to approve, among other things, the previously announced business combination (the "Business Combination") with NKGen Biotech, Inc. ("NKGen" and such special meeting, the "Special Meeting"). The Special Meeting will be reconvened at 4:00 p.m., Eastern time, on September 25, 2023. The Special Meeting will still be held virtually at https://www.cstproxy.com/grafiv/sm2023. The Company has decided to adjourn the Special M

    9/22/23 8:31:00 AM ET
    $GFOR
    Blank Checks
    Finance

    Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 20, 2023

    THE WOODLANDS, Texas, Sept. 14, 2023 /PRNewswire/ -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR.U, GFOR WS))) (the "Company" or "Graf"), announced today that on September 13, 2023, it adjourned, without conducting any business, the special meeting of its stockholders to be held to approve, among other things, the previously announced business combination (the "Business Combination") with NKGen Biotech, Inc. ("NKGen" and such special meeting, the "Special Meeting"). The Special Meeting will be reconvened at 10:00 a.m., Eastern time, on September 20, 2023. The Special Meeting will still be held virtually at https://www.cstproxy.com/grafiv/sm2023. As previously announced, the Company has recei

    9/14/23 9:00:00 AM ET
    $GFOR
    Blank Checks
    Finance

    Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 13, 2023

    THE WOODLANDS, Texas, Sept. 11, 2023 /PRNewswire/ -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR.U, GFOR WS))) (the "Company" or "Graf"), announced today that on September 8, 2023, it adjourned, without conducting any business, the special meeting of its stockholders to be held to approve, among other things, the previously announced business combination (the "Business Combination") with NKGen Biotech, Inc. ("NKGen" and such special meeting, the "Special Meeting"). The Special Meeting will be reconvened at 4:00 p.m., Eastern time, on September 13, 2023. The Special Meeting will still be held virtually at https://www.cstproxy.com/grafiv/sm2023. As previously announced, the Company has receive

    9/11/23 11:08:00 AM ET
    $GFOR
    Blank Checks
    Finance

    $GFOR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Scott Kathleen D.

    4 - NKGen Biotech, Inc. (0001845459) (Issuer)

    2/14/24 8:20:58 PM ET
    $GFOR
    Blank Checks
    Finance

    SEC Form 4 filed by Kim Yong Man

    4 - NKGen Biotech, Inc. (0001845459) (Issuer)

    2/14/24 8:19:39 PM ET
    $GFOR
    Blank Checks
    Finance

    SEC Form 4 filed by Song Paul Y.

    4 - NKGen Biotech, Inc. (0001845459) (Issuer)

    2/14/24 8:16:19 PM ET
    $GFOR
    Blank Checks
    Finance

    $GFOR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Graf Acquisition Corp. IV

    SC 13G - NKGen Biotech, Inc. (0001845459) (Subject)

    2/14/24 1:05:36 PM ET
    $GFOR
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Graf Acquisition Corp. IV (Amendment)

    SC 13G/A - NKGen Biotech, Inc. (0001845459) (Subject)

    2/14/24 6:28:12 AM ET
    $GFOR
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Graf Acquisition Corp. IV (Amendment)

    SC 13G/A - NKGen Biotech, Inc. (0001845459) (Subject)

    2/7/24 7:31:14 AM ET
    $GFOR
    Blank Checks
    Finance